Bio Green Med Solution (BGMS) Capital Expenditures Growth (3y) (2015 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) Capital Expenditures Growth (3y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | 23.48% |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | 63.07% |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | -45.93% |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | - |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | -40.95% |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 29.63% |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | 60.74% |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 27.08% |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -44.97% |
| Mar 31, 2023 | 14.47% |
| Jun 30, 2022 | 44.22% |
| Mar 31, 2022 | 25.99% |
| Dec 31, 2021 | -30.66% |
| Sep 30, 2021 | 65.10% |
| Jun 30, 2021 | -107.15% |
| Mar 31, 2021 | 52.48% |
| Dec 31, 2020 | 175.89% |
| Sep 30, 2020 | 77.11% |
| Mar 31, 2020 | 25.99% |
| Dec 31, 2018 | 44.22% |
| Sep 30, 2018 | -41.52% |
| Jun 30, 2018 | 4.00% |
| Mar 31, 2018 | 16.26% |
| Dec 31, 2017 | -34.14% |
| Sep 30, 2017 | -66.39% |
| Mar 31, 2017 | -59.89% |
| Sep 30, 2015 | 71.00% |
| Jun 30, 2015 | 100.00% |